Transdermal therapeutic system
First Claim
Patent Images
1. ) Use of a transdermal therapeutic system (TTS) comprising a pharmaceutical layer containing at least one matrix having an active ingredient, and/or an active ingredient reservoir;
- a diffusion barrier which is permeable to active ingredients and which is arranged on the skin side of the active ingredient reservoir; and
an ergoline derivative according to formula I or physiologically compatible salt thereof with an acid,
3 Assignments
0 Petitions
Accused Products
Abstract
Use of a transdermal therapeutic system (TTS) comprising a pharmaceutical layer containing at least one matrix having an active ingredient and/or an active ingredient reservoir; a diffusion barrier that is permeable to said active ingredient and arranged on the skin side of the active ingredient reservoir; and an ergoline derivative or salt thereof as an active ingredient for producing an agent for obtaining and maintaining the circadian rhythm under dopamine therapy.
110 Citations
14 Claims
-
1. ) Use of a transdermal therapeutic system (TTS) comprising a pharmaceutical layer containing at least one matrix having an active ingredient, and/or an active ingredient reservoir;
- a diffusion barrier which is permeable to active ingredients and which is arranged on the skin side of the active ingredient reservoir; and
an ergoline derivative according to formula I or physiologically compatible salt thereof with an acid, - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
- a diffusion barrier which is permeable to active ingredients and which is arranged on the skin side of the active ingredient reservoir; and
- 12. ) A TTS set for the treatment of circadian disturbances under dopamine therapy wherein the set contains a multitude of TTS elements and wherein said elements are configured for releasing different doses.
Specification